Considering the protective effect of reduced VWF activity ratios against ischemic stroke and acknowledging the heightened risk of hemorrhagic and GIB in patients with low ratios, it may be prudent to reduce the intensity of antithrombotic regimens for people with low VWF activity ratios. This evidence concerns the gene VWF and ischemic stroke.